SAS Output

21-OCT-2018 6:10

LYMPH ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1608-FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob 1 Y 1 TGR-1202 + Obinutuzumab 150 2 2 0 0 0 0 01/23/2018 294 104
        2 Lenalidomide + Obinutuzumab   2 2 1 1 0 0      
        3 CHOP + Obinutuzumab   3 3 2 0 0 0      
            7 7 3 1 0 0      
 
Yes A051301-ABC DLBCL, Auto HCT and Ibrutinib/Placebo 0 E Total Registrations   55 23 7 2 0 0 10/12/2016 156 69
            55 23 7 2 0 0      
 
    1 E Total Registrations   6 3 0 0 0 0 10/12/2016    
            6 3 0 0 0 0      
 
  EA4151-Lymph, AHCT +/-Ritux, MRD Neg 0 E Total Registrations   11 11 10 4 1 0 04/03/2018 121 58
            11 11 10 4 1 0      
 
    1 E Total Registrations   8 8 8 5 1 1 04/03/2018    
            8 8 8 5 1 1